The pharmacy benefit management subsidiary of CVS Health is favoring Humira’s biosimilars for its major formularies, with AbbVie’s branded product to be nixed on April 1, 2024.
Tag Archive for: pharmacy benefit management
CVS Health Corp. on Wednesday forecast a 2023 profit below Wall Street estimates, and also announced it agreed to pay about $5 billion over 10 years to resolve thousands of lawsuits accusing its pharmacy chain of mishandling opioid painkillers.
